Month: <span>November 2023</span>

Home / 2023 / November
Post

Lipid Nanoparticles That Deliver mRNA to T Cells Hold Promise for Autoimmune Diseases

Autoimmune disorders are among the most prevalent chronic diseases across the globe, affecting approximately 5-7% of the world’s population. Emerging treatments for autoimmune disorders focus on “adoptive cell therapies,” or those using cells from a patient’s own body to achieve immunosuppression. These therapeutic cells are recognized by the patient’s body as ‘self,’ therefore limiting side...

Phone Attachment for Pupil Measurements with Any Skin Tone
Post

Phone Attachment for Pupil Measurements with Any Skin Tone

NOVEMBER 20TH, 2023   CONN HASTINGS A research team at the University of California San Diego have developed a smartphone attachment that can provide information on changes in pupil size, which can be used to assess neurological phenomena, such as traumatic brain injury and Alzheimer’s disease. Such changes in pupil size have been difficult to characterize...

Microautophagy is essential for preventing aging
Post

Microautophagy is essential for preventing aging

Researchers from Osaka University have shown for the first time that damaged lysosomes are repaired by a process called microautophagy, which is essential for preventing aging Peer-Reviewed Publication OSAKA UNIVERSITY OVERVIEW: LYSOSOMES ARE REPAIRED BY ESCRT-DRIVEN MICROAUTOPHAGY, AND STK38 AND GABARAPS ARE KEY REGULATORS OF THIS PROCESS BY RECRUITING ESCRTS TO LYSOSOMES. THESE REGULATORS ARE...

Coffee grounds may hold key to preventing neurodegenerative diseases
Post

Coffee grounds may hold key to preventing neurodegenerative diseases

UTEP researchers create therapy that is both economical, sustainable Peer-Reviewed Publication UNIVERSITY OF TEXAS AT EL PASO A TEAM LED BY JYOTISH KUMAR (RIGHT), A DOCTORAL STUDENT IN THE DEPARTMENT OF CHEMISTRY AND BIOCHEMISTRY AT UTEP, AND OVERSEEN BY MAHESH NARAYAN, PH.D. (SECOND FROM LEFT), A PROFESSOR AND FELLOW OF THE ROYAL SOCIETY OF CHEMISTRY...

Post

Bone growth drug may reduce sudden infant death syndrome in children with common form of dwarfism

Peer-Reviewed Publication MURDOCH CHILDRENS RESEARCH INSTITUTE A drug that boosts bone growth in children with the most common form of dwarfism, may also reduce their chances of sudden infant death syndrome, sleep apnoea and needing surgery, according to a new study. The international research trial, led by Murdoch Children’s Research Institute (MCRI) and published in...

Gene linked to persistent stuttering into adulthood uncovered
Post

Gene linked to persistent stuttering into adulthood uncovered

by Danielle Galvin, University of Melbourne Credit: CC0 Public Domain A new study led by University of Melbourne researchers has discovered a link between a new gene pathway and structural brain anomalies in some people who stutter into adulthood, opening up promising research avenues to enhance the understanding of persistent developmental stuttering. Published in the journal...

New Alzheimer’s drug shines light on need for assessments to head off ‘a tsunami of cognitive afflictions’
Post

New Alzheimer’s drug shines light on need for assessments to head off ‘a tsunami of cognitive afflictions’

by University of Southern California Credit: Pixabay/CC0 Public Domain Two stories dominated Alzheimer’s news this year: The FDA’s approval of Leqembi, the first drug to slow progression of the disease, and a surprising study showing that mild cognitive impairment is wildly underdiagnosed. “For mild cognitive impairment, or MCI, caused by Alzheimer’s disease, the earlier you treat...

Personalized cancer medicine: Humans make better treatment decisions than AI, says study
Post

Personalized cancer medicine: Humans make better treatment decisions than AI, says study

by Charité—Universitätsmedizin Berlin Organoid model of a tumor. Unchecked cell growth and targeted treatments can be simulated in these models. Credit: Ana Cristina Afonseca Pestana Treating cancer is becoming increasingly complex, but also offers more and more possibilities. After all, the better a tumor’s biology and genetic features are understood, the more treatment approaches there...

Myneurva Announces New Partnership with Regenerative Medical Group & Upcoming Brain Training Center in New Jersey
Post

Myneurva Announces New Partnership with Regenerative Medical Group & Upcoming Brain Training Center in New Jersey

TOGETHER WE ARE STRONGER  Myneurva Announces New Partnership with Regenerative Medical Group & Upcoming Brain Training Center in New Jersey   We are elated to share with you an exciting development in our pursuit of clinical excellence with the collaborative partnership between Regenerative Medical Group (RMG) and Myneurva. We have recently introduced Myneurva’s neurofeedback system, under...

Breakthroughs hailed in childhood TB prevention
Post

Breakthroughs hailed in childhood TB prevention

by Claudia Caruana and Ruth Douglas, SciDev.Net More funding is needed to combat Koch’s bacillus, the bacteria responsible for tuberculosis. Credit: NIAID, ( CC BY 2.0 ) Taking a common antibiotic could more than half the risk of children becoming sick with multidrug resistant tuberculosis (MDR-TB), according to findings presented this week at a conference...